New Key Statistics Module, Z-Score and F-Score
NAS:REGN Key Ratios
Market Cap $ M | 108,046.80 |
Enterprise Value $ M | 100,230.60 |
P/E(ttm) | 28.97 |
PE Ratio without NRI | 25.52 |
Forward PE Ratio | 22.42 |
Price/Book | 4.00 |
Price/Sales | 8.53 |
Price/Free Cash Flow | 28.48 |
Price/Owner Earnings | 39.25 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 13,100.00 |
EPS (TTM) $ | 33.85 |
Beneish M-Score | -2.51 |
10-y EBITDA Growth Rate % | 24.90 |
5-y EBITDA Growth Rate % | 17.70 |
y-y EBITDA Growth Rate % | -10.80 |
EV-to-EBIT | 24.37 |
EV-to-EBITDA | 22.03 |
PEG | 1.44 |
Shares Outstanding M | 110.19 |
Net Margin (%) | 29.45 |
Operating Margin % | 30.45 |
Pre-tax Margin (%) | 30.86 |
Quick Ratio | 4.51 |
Current Ratio | 5.27 |
ROA % (ttm) | 12.03 |
ROE % (ttm) | 15.38 |
ROIC % (ttm) | 19.71 |
Dividend Yield % | -- |
Altman Z-Score | 11.24 |
REGN Number of Guru Trades
REGN Volume of Guru Trades
Gurus Latest Trades with NAS:REGN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:REGN is held by these investors
Total 7
Regeneron Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:REGN
Total 0- 1